Skip to main content

Peer Review reports

From: DNMT3A low-expression is correlated to poor prognosis in childhood B-ALL and confers resistance to daunorubicin on leukemic cells

Original Submission
11 Jul 2021 Submitted Original manuscript
18 Aug 2021 Reviewed Reviewer Report
28 Sep 2021 Reviewed Reviewer Report - Juan Manuel Mejía-Aranguré
29 Oct 2021 Author responded Author comments - Weijing Li
Resubmission - Version 2
29 Oct 2021 Submitted Manuscript version 2
3 Aug 2022 Reviewed Reviewer Report
7 Sep 2022 Author responded Author comments - Weijing Li
Resubmission - Version 3
7 Sep 2022 Submitted Manuscript version 3
17 Oct 2022 Reviewed Reviewer Report
29 Nov 2022 Author responded Author comments - Weijing Li
Resubmission - Version 4
29 Nov 2022 Submitted Manuscript version 4
20 Dec 2022 Reviewed Reviewer Report
18 Jan 2023 Author responded Author comments - Weijing Li
Resubmission - Version 5
18 Jan 2023 Submitted Manuscript version 5
Publishing
8 Mar 2023 Editorially accepted
18 Mar 2023 Article published 10.1186/s12885-023-10724-6

You can find further information about peer review here.

Back to article page